Cargando…
A missense mutation in both hMSH2 andAPC in an Ashkenazi Jewish HNPCC kindred: implications for clinical screening
Autores principales: | YUAN, ZHI QIANG, WONG, NORA, FOULKES, WILLIAM D, ALPERT, LESLEY, MANGANARO, FORTUNATO, ANDREUTTI-ZAUGG, CORINNE, IGGO, RICHARD, ANTHONY, KIRA, HSIEH, EUGENE, REDSTON, MARK, PINSKY, LEONARD, TRIFIRO, MARK, GORDON, PHILIP H, LASKO, DANA |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3622028/ https://www.ncbi.nlm.nih.gov/pubmed/10528862 http://dx.doi.org/10.1136/jmg.36.10.792 |
Ejemplares similares
-
hMSH2 is the most commonly mutated MMR gene in a cohort of Greek HNPCC patients
por: Apessos, A, et al.
Publicado: (2005) -
Genetic architecture of prostate cancer in the Ashkenazi Jewish population
por: Vijai, J, et al.
Publicado: (2011) -
MutS Homologues hMSH4 and hMSH5: Genetic Variations, Functions, and Implications in Human Diseases
por: Clark, Nicole, et al.
Publicado: (2013) -
Loss or Somatic Mutations of hMSH2 Occur in Hereditary Nonpolyposis Colorectal Cancers with hMSH2 Germline Mutations
por: Lu, Shi‐Long, et al.
Publicado: (1996) -
Beyond the “Jewish panel”: the importance of offering expanded carrier screening to the Ashkenazi Jewish population
por: Dolitsky, Shelley, et al.
Publicado: (2020)